Bliss GVS Pharma Ltd

NSE: BLISSGVS · BSE: 506197 · Pharmaceuticals & Biotechnology · 40 announcements

Share price: ₹685.00
Market cap: ₹7,284 Cr
Revenue (annual): ₹927.1 Cr
Net profit (annual): ₹129.1 Cr
P/E (TTM): 53.5×Sector 47.4×
Promoter holding: 35.01%-0.35% QoQ
FII holding: 8.07%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Open Offer 3 Employee Stock Options 3 Annual General Meeting 3 Other Announcement 2 Capital Structure Change 2 Management Change 1 Financial Results 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

22 Sep 2026 16:00 IST BSE

Annual General Meeting

Bliss GVS Pharma Annual General Meeting

Bliss GVS Pharma Ltd reported the voting results of its postal ballot. Members approved the appointment of Mr. Santosh Parab as a Non-Executive and Non-Independent Director.

Read the filing ↗

20 Aug 2026 17:27 IST BSE

Annual General Meeting

Bliss GVS Pharma Annual General Meeting

Bliss GVS Pharma Ltd issued a Postal Ballot Notice to seek shareholder approval for the appointment of Mr. Santosh Parab as a Director.

Read the filing ↗

15 Jul 2026 18:37 IST BSE

Annual General Meeting

Bliss GVS Pharma Annual General Meeting

Bliss GVS Pharma concluded its 41st AGM on July 15, 2026. Shareholders approved a 100% final dividend of Re. 1.00 per share for FY 2025-26.

Read the filing ↗